Abstract
To the Editor. — In a recent issue of Pediatrics , Healy et al1 described the continued benefit and safety of fluconazole prophylaxis in infants weighing <1000 g in preventing invasive Candida infections and eliminating these infections as a cause of mortality in their NICU. The efficacy and safety of preventing these invasive Candida infections with fluconazole prophylaxis has been proven in single and multicenter randomized trials in preterm infants without the development of resistance.2,3 In addition, retrospective studies have added safety and efficacy data from …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
